Solid Forms of a Thiophosphoramidate Nucleotide Prodrug
    3.
    发明申请
    Solid Forms of a Thiophosphoramidate Nucleotide Prodrug 有权
    固体形式的硫代磷酰胺酸核苷酸前体药物

    公开(公告)号:US20130266538A1

    公开(公告)日:2013-10-10

    申请号:US13794380

    申请日:2013-03-11

    摘要: The present application relates to solid state forms, for example, crystalline forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, pharmaceutical compositions that can include one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, and methods of treating or ameliorating diseases and/or conditions with one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate. Also disclosed herein are methods of treating diseases and/or conditions with one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate in combination with one or more other agents.

    摘要翻译: 本申请涉及固态形式,例如2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺的结晶形式,其可以包括 一种或多种固体形式的2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺酸盐,以及用一种或多种硫代磷酸酰胺酯治疗或改善疾病和/或病症的方法 更多固体形式的2'-C-甲基尿苷-5' - (O-苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺。 本文还公开了组合治疗具有一种或多种固体形式的2'-C-甲基尿苷-5' - (邻苯基-N-(S)-1-(异丙氧基羰基)乙基)硫代磷酰胺的疾病和/或病症的方法 与一个或多个其他代理。